Dual role of microRNAs in cancer metastasis

[1]  M. Lulli,et al.  miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration , 2022, Cancers.

[2]  M. Alikhani,et al.  Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells , 2022, Cells.

[3]  Shuyi Wang,et al.  EMT‐cancer cells‐derived exosomal miR‐27b‐3p promotes circulating tumour cells‐mediated metastasis by modulating vascular permeability in colorectal cancer , 2021, Clinical and translational medicine.

[4]  M. Azad,et al.  Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks , 2021, Journal of Cancer Research and Therapeutics.

[5]  A. Dorgalaleh,et al.  Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage , 2021, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  A. Atashi,et al.  Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics. , 2021, Epigenomics.

[7]  S. Rostami,et al.  Promoter Methylation Status and Expression Levels of RASSF1A Gene in Different Phases of Acute Lymphoblastic Leukemia (ALL) , 2021, International journal of hematology-oncology and stem cell research.

[8]  K. Mortezaee,et al.  Steps in metastasis: an updated review , 2021, Medical Oncology.

[9]  M. Azad,et al.  CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy. , 2020, Epigenomics.

[10]  Junhai Huang,et al.  microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells. , 2020, American journal of translational research.

[11]  Elaheh Ferdosi-Shahandashti,et al.  The Antihelminthic Drug, Mebendazole, Induces Apoptosis in Adult T-Cell Leukemia/Lymphoma Cancer Cells: In-Vitro Trial , 2020, International journal of hematology-oncology and stem cell research.

[12]  M. Joupari,et al.  Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse , 2020, Scientific Reports.

[13]  Guoxiang Wang,et al.  Clinical significance and functions of miR-203a-3p/AVL9 axis in human non-small-cell lung cancer. , 2020, Personalized medicine.

[14]  Hai-Feng Zhang,et al.  MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 , 2020, Cancer management and research.

[15]  Junjian Liu,et al.  MicroRNA-31 inhibits the growth and metastasis and enhances drug sensitivity of the human colon cancer cells by targeting PAX6. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[16]  I. Georgakopoulos-Soares,et al.  EMT Factors and Metabolic Pathways in Cancer , 2020, Frontiers in Oncology.

[17]  Ying Yan,et al.  Effect and Mechanism of miR-26a-5p on Proliferation and Apoptosis of Hepatocellular Carcinoma Cells , 2020, Cancer management and research.

[18]  M. Ahmadvand,et al.  Upregulated miR-410 is linked to poor prognosis in colorectal cancer , 2020 .

[19]  Marzieh Ebrahimi,et al.  Metastasis inhibition by BRMS1 and miR-31 replacement therapy in claudin-low cell lines , 2020, Iranian journal of basic medical sciences.

[20]  F. Orso,et al.  Role of miRNAs in tumor and endothelial cell interactions during tumor progression. , 2020, Seminars in cancer biology.

[21]  Q. Fu,et al.  VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer , 2020, International journal of cancer.

[22]  Dexi Chen,et al.  The significance of exosomes in the development and treatment of hepatocellular carcinoma , 2020, Molecular Cancer.

[23]  R. Oskuee,et al.  Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity , 2020, Stem Cell Reviews and Reports.

[24]  Lan Xu,et al.  miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways , 2020, OncoTargets and therapy.

[25]  W. Wang,et al.  Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  X. Zhou,et al.  MiR-126 inhibits cell migration and invasion by targeting ADAM9 in oral squamous cell carcinoma. , 2019, European review for medical and pharmacological sciences.

[27]  L. Ding,et al.  MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer , 2019, Cells.

[28]  Z. Jie,et al.  MiR-21 Promotes the Invasion and Metastasis of Gastric Cancer Cells by Activating Epithelial-Mesenchymal Transition , 2019, European Surgical Research.

[29]  Lei Yuan,et al.  Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway. , 2019, Oncology letters.

[30]  G. Calin,et al.  Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer. , 2019, Seminars in cancer biology.

[31]  Wenguo Jiang,et al.  MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and Growth , 2019, AntiCancer Research.

[32]  Boo‐Yong Lee,et al.  Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells , 2019, Front. Oncol..

[33]  Shusen Zheng,et al.  MicroRNA-203a-3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma , 2019, Oncology reports.

[34]  Q. Bian,et al.  NF-κB-regulation of miR-155, via SOCS1/STAT3, is involved in the PM2.5-accelerated cell cycle and proliferation of human bronchial epithelial cells. , 2019, Toxicology and applied pharmacology.

[35]  Sanjeev Raghuwanshi,et al.  Long non-coding RNA: Classification, biogenesis and functions in blood cells. , 2019, Molecular immunology.

[36]  K. Polyak,et al.  Metastasis as a systemic disease: molecular insights and clinical implications. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[37]  J. Tu,et al.  microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1 , 2019, BMC Cancer.

[38]  H. Wang,et al.  [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R]. , 2019, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[39]  Yan Wang,et al.  Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1. , 2019, International journal of biological macromolecules.

[40]  Changli Wang,et al.  miR-195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF , 2019, Molecular medicine reports.

[41]  Zhong Ji,et al.  MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9. , 2019, European review for medical and pharmacological sciences.

[42]  E. Denisov,et al.  Intravasation as a Key Step in Cancer Metastasis , 2019, Biochemistry (Moscow).

[43]  C. Alonso-González,et al.  Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin , 2019, Cancers.

[44]  Wengui Xu,et al.  MicroRNA‐520c‐3p functions as a novel tumor suppressor in lung adenocarcinoma , 2019, The FEBS journal.

[45]  Xianan Li,et al.  MiR-9 promotes synovial sarcoma cell migration and invasion by directly targeting CDH1. , 2019, The international journal of biochemistry & cell biology.

[46]  P. ten Dijke,et al.  TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis , 2019, International journal of molecular sciences.

[47]  Zheying Zhang,et al.  Long intergenic noncoding RNA 00707 promotes colorectal cancer cell proliferation and metastasis by sponging miR-206 , 2019, OncoTargets and therapy.

[48]  L. Jia,et al.  Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT , 2019, OncoTargets and therapy.

[49]  Hongyun Wang,et al.  The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1 , 2019, Hereditas.

[50]  T. Rohan,et al.  A miRNA Expression Signature in Breast Tumor Tissue Is Associated with Risk of Distant Metastasis. , 2019, Cancer research.

[51]  Fanfan Li.  Expression and correlation of miR-124 and miR-126 in breast cancer , 2019, Oncology letters.

[52]  Wei Hu,et al.  Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5. , 2019, American journal of cancer research.

[53]  Tao Wang,et al.  MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma , 2019, Journal of Experimental & Clinical Cancer Research.

[54]  W. Fan,et al.  The role and mechanisms of action of microRNAs in cancer drug resistance , 2019, Clinical Epigenetics.

[55]  Liling Tang,et al.  MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer , 2019, Journal of Experimental & Clinical Cancer Research.

[56]  Li Ma,et al.  New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis , 2019, Cancers.

[57]  B. Baradaran,et al.  Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[58]  A. Azmi,et al.  miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma. , 2019, The American journal of pathology.

[59]  M. Sang,et al.  miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. , 2018, Pathology, research and practice.

[60]  J. Rui,et al.  miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/β-catenin signaling pathway , 2018, Oncology letters.

[61]  A. Moustakas,et al.  Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β , 2018, International journal of molecular sciences.

[62]  I. Kiss,et al.  Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer , 2018, In Vivo.

[63]  H. Chen,et al.  MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A. , 2018, European review for medical and pharmacological sciences.

[64]  A. Atashi,et al.  A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future. , 2018, Current Stem Cell Research & Therapy.

[65]  Xi Cheng,et al.  LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[66]  G. Calin,et al.  OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers , 2018, Scientific Reports.

[67]  M. Gullerová,et al.  Noncanonical functions of microRNA pathway enzymes – Drosha, DGCR8, Dicer and Ago proteins , 2018, FEBS letters.

[68]  Yongyong Xie,et al.  MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[69]  K. To,et al.  MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside , 2018, World journal of gastroenterology.

[70]  Gonghao Zhang,et al.  TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma , 2018, OncoTargets and therapy.

[71]  Shan Xu,et al.  MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells. , 2018, Oncology letters.

[72]  M. Azad,et al.  Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways , 2018, Clinical lymphoma, myeloma & leukemia.

[73]  Ying Zhang,et al.  miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells , 2018, Oncology letters.

[74]  C. Zou,et al.  CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma , 2018, Journal of experimental & clinical cancer research : CR.

[75]  Sandip Kar,et al.  Alteration in microRNA‐17‐92 dynamics accounts for differential nature of cellular proliferation , 2018, FEBS letters.

[76]  Jianru Xiao,et al.  microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11 , 2018, Molecular Cancer.

[77]  M. Azad,et al.  Effect of calprotectin subunit S100A9 on the expression and methylation of OCLN in human melanoma cell line A-375. , 2017, Turkish journal of biology = Turk biyoloji dergisi.

[78]  Daya Luo,et al.  Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis , 2017, Molecular Cancer.

[79]  M. Manikandan,et al.  Dysregulation of miR-200 family microRNAs and epithelial-mesenchymal transition markers in oral squamous cell carcinoma. , 2017, Oncology letters.

[80]  Y. Pekarsky,et al.  BCL2 and miR-15/16: from gene discovery to treatment , 2017, Cell Death and Differentiation.

[81]  L. Yin,et al.  MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma , 2017, Journal of Experimental & Clinical Cancer Research.

[82]  B. Han,et al.  MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.

[83]  Benyan Wu,et al.  MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer. , 2017, Oncology reports.

[84]  Feng-jun Liu,et al.  microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1. , 2017, Pharmazie.

[85]  W. Krzyzosiak,et al.  Stress-induced changes in miRNA biogenesis and functioning , 2017, Cellular and Molecular Life Sciences.

[86]  Tirdad Rahmani,et al.  Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia , 2017, International journal of hematology-oncology and stem cell research.

[87]  L. Jia,et al.  Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer , 2017, Cell Death & Disease.

[88]  Yingyi Wang,et al.  MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12 , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[89]  Yong Wang,et al.  MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma , 2017, Oncology letters.

[90]  Shu-guang Wang,et al.  miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis , 2017, BMC Cancer.

[91]  Feiran Wang,et al.  miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. , 2017, Oncology letters.

[92]  U. Stein,et al.  Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression , 2017, Oncotarget.

[93]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[94]  U. Stein,et al.  Underlying Mechanisms for Distant Metastasis - Molecular Biology , 2017, Visceral Medicine.

[95]  F. Rojo,et al.  The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene , 2017, Scientific Reports.

[96]  Su-jin Yang,et al.  MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. , 2016, Gene.

[97]  B. Baradaran,et al.  Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[98]  Shiyong Xin,et al.  MicroRNA-124 (MiR-124) Inhibits Cell Proliferation, Metastasis and Invasion in Colorectal Cancer by Downregulating Rho-Associated Protein Kinase 1(ROCK1) , 2016, Cellular Physiology and Biochemistry.

[99]  P. Altevogt,et al.  Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer , 2016, BMC Cancer.

[100]  Jie Lin,et al.  miR-126: A novel regulator in colon cancer. , 2016, Biomedical reports.

[101]  V. Rani,et al.  Exploring miRNA based approaches in cancer diagnostics and therapeutics. , 2016, Critical reviews in oncology/hematology.

[102]  J. An,et al.  [Role of miR-155 in invasion and metastasis of lung adenocarcinoma A549 cells]. , 2016, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[103]  Xiao-yu Wu,et al.  MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene1 , 2016, Translational oncology.

[104]  H. Liu,et al.  miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells , 2016, Tumor Biology.

[105]  Y. Li,et al.  Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer , 2016, Cancer biology & therapy.

[106]  Andreas Nyström,et al.  Cancer Metastases: Early Dissemination and Late Recurrences , 2015, Cancer growth and metastasis.

[107]  Zhilong Yan,et al.  MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer , 2015, World Journal of Surgical Oncology.

[108]  Helin Zhang,et al.  MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4. , 2015, American journal of translational research.

[109]  De Chen,et al.  Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer , 2015, PloS one.

[110]  Ping Liu,et al.  Dual‐Functions of miR‐373 and miR‐520c by Differently Regulating the Activities of MMP2 and MMP9 , 2015, Journal of cellular physiology.

[111]  Juntaro Matsuzaki,et al.  Role of MicroRNAs-221/222 in Digestive Systems , 2015, Journal of clinical medicine.

[112]  Aamir Ahmad,et al.  Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 , 2015, BMC Cancer.

[113]  P. Ismail,et al.  MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. , 2015, Pharmacological research.

[114]  Di Wu,et al.  MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer , 2015, Oncotarget.

[115]  Li Ma,et al.  The emerging molecular machinery and therapeutic targets of metastasis. , 2015, Trends in pharmacological sciences.

[116]  E. Bowman,et al.  Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer , 2015, PloS one.

[117]  Xuefeng Liu,et al.  miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W , 2015, Tumor Biology.

[118]  M. Goudarzi,et al.  Short View of Leukemia Diagnosis and Treatment in Iran , 2015, International journal of hematology-oncology and stem cell research.

[119]  Yusuke Yoshioka,et al.  Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier , 2015, Nature Communications.

[120]  Fangzhou Song,et al.  MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met , 2015, Tumor Biology.

[121]  Wei Chen,et al.  Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma , 2015, Oncotarget.

[122]  W. Cong,et al.  Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules , 2015, Oncotarget.

[123]  Narayana M. Sekar,et al.  Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy , 2015, ACS nano.

[124]  Weiying Zhou,et al.  Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis , 2015, Nature Cell Biology.

[125]  Feipeng Zhao,et al.  MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma , 2014, Molecular Cancer.

[126]  G. Calin,et al.  Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[127]  Y. Pekarsky,et al.  Role of miR-15/16 in CLL , 2014, Cell Death and Differentiation.

[128]  Zhang Zhang,et al.  MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2 , 2014, Medical Oncology.

[129]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[130]  N. Kosaka,et al.  Clinical Relevance and Therapeutic Significance of MicroRNA‐133a Expression Profiles and Functions in Malignant Osteosarcoma‐Initiating Cells , 2014, Stem cells.

[131]  L. Feng,et al.  Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells , 2014, Leukemia.

[132]  A. Russo,et al.  Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? , 2013, Expert opinion on therapeutic targets.

[133]  Fang Wang,et al.  The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia , 2013, Cell Death and Differentiation.

[134]  Wei Zhao,et al.  miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells , 2013, Molecular and Cellular Biochemistry.

[135]  Francesca Orso,et al.  miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. , 2013, Cancer research.

[136]  N. Zaffaroni,et al.  MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets. , 2013, Current Medicinal Chemistry.

[137]  Wei Zhang,et al.  Overexpression of miR -155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3 , 2013, PloS one.

[138]  J. Ju,et al.  MicroRNA , 2013, Clinical chemistry and laboratory medicine.

[139]  C. C. Sage,et al.  Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis , 2013, Oncogene.

[140]  Jing Bai,et al.  Dissection of the potential characteristic of miRNA-miRNA functional synergistic regulations. , 2013, Molecular bioSystems.

[141]  B. Czerniak,et al.  The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells , 2012, The Journal of Biological Chemistry.

[142]  Aamir Ahmad,et al.  The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis , 2012, International journal of molecular sciences.

[143]  Kai Fu,et al.  Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. , 2012, Cancer cell.

[144]  Peijing Zhang,et al.  LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker , 2012, Nature Medicine.

[145]  Zhaoshi Jiang,et al.  Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway , 2012, The EMBO journal.

[146]  Pei-ying Zhang,et al.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[147]  Hsien-Da Huang,et al.  miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. , 2012, Cancer research.

[148]  Q. Cui,et al.  Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs , 2012, Oncogene.

[149]  Manel Esteller,et al.  Dysregulation of microRNAs in cancer: Playing with fire , 2011, FEBS letters.

[150]  Qing‐Yu He,et al.  Global identification of miR‐373‐regulated genes in breast cancer by quantitative proteomics , 2011, Proteomics.

[151]  L. Matrisian,et al.  Rapid Extravasation and Establishment of Breast Cancer Micrometastases in the Liver Microenvironment , 2010, Molecular Cancer Research.

[152]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[153]  Layla Alhasan.  MiR-126 Modulates Angiogenesis in Breast Cancer by Targeting VEGF-A -mRNA , 2019, Asian Pacific journal of cancer prevention : APJCP.

[154]  B. Nie,et al.  Long non-coding RNA GAS5 regulates human B lymphocytic leukaemia tumourigenesis and metastasis by sponging miR-222. , 2019, Cancer biomarkers : section A of Disease markers.

[155]  M. Sahmani,et al.  Evaluating the Role of PTEN Promoter Methylation in Patients Predisposed to Hypercoagulable States via Methylation Specific PCR. , 2019, Reports of biochemistry & molecular biology.

[156]  Y. Wen,et al.  Down-regulation of microRNA-21 inhibits cell proliferation and invasion of high-invasion liver cancer stem cells. , 2018, European review for medical and pharmacological sciences.

[157]  Juan Fan,et al.  MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro. , 2017, American journal of translational research.

[158]  Weiling Huang.  MicroRNAs: Biomarkers, Diagnostics, and Therapeutics. , 2017, Methods in molecular biology.

[159]  Chandrasekhar Kanduri,et al.  Long Noncoding RNA: Genome Organization and Mechanism of Action. , 2017, Advances in experimental medicine and biology.

[160]  G. Calin,et al.  Cancer Hallmarks and MicroRNAs: The Therapeutic Connection , 2017, Advances in cancer research.

[161]  L. Ma.  MicroRNA and Metastasis. , 2016, Advances in cancer research.

[162]  Z. Shao,et al.  Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43. , 2015, European review for medical and pharmacological sciences.

[163]  L. O’Driscoll,et al.  Intracellular and extracellular microRNAs in breast cancer. , 2011, Clinical chemistry.